ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,975,827 | +4.9% | 170,609 | 0.0% | 1.19% | +14.6% |
| Q2 2023 | $15,226,853 | -43.5% | 170,609 | -32.1% | 1.04% | -49.2% |
| Q1 2023 | $26,953,714 | +33.0% | 251,387 | +51.5% | 2.05% | +15.4% |
| Q4 2022 | $20,265,886 | +42.7% | 165,937 | +20.6% | 1.78% | +34.9% |
| Q3 2022 | $14,204,000 | +42.9% | 137,554 | +28.6% | 1.32% | +40.3% |
| Q2 2022 | $9,940,000 | -54.8% | 106,931 | -42.9% | 0.94% | -40.0% |
| Q1 2022 | $21,993,000 | +45.8% | 187,401 | +67.1% | 1.56% | +63.9% |
| Q4 2021 | $15,084,000 | +248.8% | 112,122 | +313.2% | 0.96% | +202.2% |
| Q3 2021 | $4,325,000 | +692.1% | 27,134 | +484.4% | 0.32% | +544.9% |
| Q1 2019 | $546,000 | – | 4,643 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |